Common Contracts
5 similar Securities Purchase Agreement contracts by Biocept Inc, Celsion CORP, InMed Pharmaceuticals Inc., others
SURROZEN, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 2nd, 2024 • Surrozen, Inc./De • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 1, 2024, by and between Surrozen, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 10th, 2023 • Virax Biolabs Group LTD • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 8, 2023, between Virax Biolabs Group Limited, a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 6th, 2022 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 1, 2022, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 24th, 2018 • Biocept Inc • Services-medical laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 20, 2018, between Biocept, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 17th, 2016 • Celsion CORP • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 13, 2016, between Celsion Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
